Apolipoprotein M T-778C polymorphism is associated with serum lipid levels and the risk of coronary artery disease in the Chinese population: a meta-analysis

Lipids in Health and Disease - Tập 12 - Trang 1-10 - 2013
Zhi Zhang1, Guang Chu1, Rui-Xing Yin2
1Department of Cardiology, People’s Republic of China, Shanghai First People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
2Department of Cardiology, People’s Republic of China, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi

Tóm tắt

The apolipoprotein M (APOM) T-778C gene polymorphism has been associated with serum lipid levels and the risk of coronary artery disease (CAD), but the results are inconclusive. The purpose of this meta-analysis was to detect the association between the APOM T-778C polymorphism and serum lipid levels and the risk of CAD in the Chinese population. Databases of MEDLINE, EMBASE, the Cochrane Library and CNKI were systematically searched. Data were extracted using standardized methods. The association was assessed by mean difference (MD) with 95% confidence intervals (CI) or odds ratio (OR) with 95% CI. Ten studies with 4,413 patients were included in this meta-analysis. Pooled effects indicated that CT+CC group had higher levels of total cholesterol (TC) (MD:-0.36, 95% CI: -0.53 – -0.19, P < 0.0001) and low-density lipoprotein cholesterol (LDL-C) (MD: -0.08, 95% CI: -0.16 – -0.01, P = 0.03) than TT group. There was no difference in the levels of triglyceride (MD: 0.06, 95% CI: -0.04 – 0.15, P = 0.22) and high-density lipoprotein cholesterol (MD: 0.00, 95% CI: -0.03–0.03, P = 0.93) between TT and CT+CC groups. Pooled effects showed that CAD group had higher CT+CC genotype frequency than control group (OR: 1.97, 95% CI: 1.62–2.39, P < 0.00001; heterogeneity test x2 = 2.96, P = 0.71, I2 = 0%). The results of the current meta-analysis show that the CT+CC group has higher levels of TC and LDL-C than the TT group. Moreover, there is also a prominent association between APOM T-778C polymorphism and the risk of CAD in the Chinese population, the CT+CC genotype is associated with increased risk of CAD.

Tài liệu tham khảo

McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, Luepker RV: Recent trends in acute coronary heart disease–mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med. 1996, 334: 884-890. 10.1056/NEJM199604043341403

Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986, 256: 2835-2838. 10.1001/jama.1986.03380200073024

Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847. 10.1161/01.CIR.97.18.1837

Shekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S, Raynor WJ: Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med. 1981, 304: 65-70. 10.1056/NEJM198101083040201

Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996, 3: 213-219. 10.1097/00043798-199604000-00014

Marz W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, Winkelmann BR: Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation. 2004, 110: 3068-3074. 10.1161/01.CIR.0000146898.06923.80

Durrington PN, Hunt L, Ishola M, Kane J, Stephens WP: Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Br Heart J. 1986, 56: 206-212. 10.1136/hrt.56.3.206

Kwiterovich PO, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA: Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol. 1992, 69: 1015-1021. 10.1016/0002-9149(92)90856-T

Heller DA, De Faire U, Pedersen NL, Dahlen G, McClearn GE: Genetic and environmental influences on serum lipid levels in twins. N Engl J Med. 1993, 328: 1150-1156. 10.1056/NEJM199304223281603

Visvikis-Siest S, Marteau JB: Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol. 2006, 17: 139-151. 10.1097/01.mol.0000217895.67444.de

Xie T, Rowen L, Aguado B, Ahearn ME, Madan A, Qin S, Campbell RD, Hood L: Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res. 2003, 13: 2621-2636. 10.1101/gr.1736803

Wolfrum C, Poy MN, Stoffel M: Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med. 2005, 11: 418-422. 10.1038/nm1211

Luo G, Zhang X, Nilsson-Ehle P, Xu N: Apolipoprotein M. Lipids Health Dis. 2004, 3: 21- 10.1186/1476-511X-3-21

Huang B, Zhang S, Huang YH, Han F, Zheng YY, Jiang J: A study on the associativity of apolipoprotein M gene pormoter T-778 C polymorphism with coronary heart disease among Han people of Guizhou. Journal of Guiyang Medical College. 2009, 34 (3): 297-299.

Jiao GQ, Yuan ZX, Xue YS, Yang CJ, Lu CB, Lu ZQ, Xiao MD: A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese. Clin Biochem. 2007, 40: 1108-1112. 10.1016/j.clinbiochem.2007.04.023

Ma L, Li B, Wang X: The study on the interrelation between polymorphism of apolipoprotein M and in the ratio of apoB/apoAl patients with coronary heart disease. China Modern Medicine. 2011, 18: 42-43.

Mo Y, Huang Y, Huang J: The relationship between apolipoprotein M gene polymorphism and serum lipids in Han, Miao and Buyi nationalities of Guizhou Province. Journal of Guiyang Medical College. 2011, 36: 477-480.

Niu N, Zhu X, Liu Y, Du T, Wang X, Chen D, Sun B, Gu HF: Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese. Diabetes Metab Res Rev. 2007, 23: 21-25. 10.1002/dmrr.641

Wang X, Li B: Discussion of the relationship between apoM genotype and lipoprotein (a) in patients of coronary heart disease. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease. 2009, 7: 654-656.

Wu X, Niu N, Brismar K, Zhu X, Wang X, Efendic S, Du T, Liu Y, Gu HF: Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes. Clin Biochem. 2009, 42: 17-21. 10.1016/j.clinbiochem.2008.10.008

Zhao D, He Z, Qin X, Li L, Liu F, Deng S: Association of apolipoprotein M gene polymorphisms with ischemic stroke in a Han Chinese population. J Mol Neurosci. 2010, 43: 370-375. 10.1016/j.mcn.2010.01.004

Zheng L, Luo G, Zhang X, Zhang J, Zhu J, Wei J, Mu Q, Chen L, Nilsson-Ehle P, Xu N: Determination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseases. Int J Gen Med. 2009, 2: 177-182.

Zhang X, Liu T, Cai W, Yan C, Liang Z, Sun Y, Feng X, Han Y: Polymorphisms in the ApoM gene confer the susceptibility to acute coronary syndrome. Shan Dong Yi Yao. 2012, 52: 1-3.

Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315: 629-634. 10.1136/bmj.315.7109.629

Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ. 2003, 327: 557-560. 10.1136/bmj.327.7414.557

Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. Edited by: Higgins JPTGS. 2008, Available fromhttp://www.cochrane-handbook.org. 2008, Available from. 2008

Whitney EJ, Krasuski RA, Personius BE, Michalek JE, Maranian AM, Kolasa MW, Monick E, Brown BG, Gotto AM: A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events. Ann Intern Med. 2005, 142: 95-104. 10.7326/0003-4819-142-2-200501180-00008

Xu N, Dahlback B: A novel human apolipoprotein (apoM). J Biol Chem. 1999, 274: 31286-31290. 10.1074/jbc.274.44.31286

Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003, 33: 177-182. 10.1038/ng1071

Ruixing Y, Qiming F, Dezhai Y, Shuquan L, Weixiong L, Shangling P, Hai W, Yongzhong Y, Feng H, Shuming Q: Comparison of demography, diet, lifestyle, and serum lipid levels between the Guangxi Bai Ku Yao and Han populations. J Lipid Res. 2007, 48: 2673-2681. 10.1194/jlr.M700335-JLR200

Thông tin
Thông tin xuất bản

Lipids in Health and Disease

Tập 12

1-10

Thông tin tác giả